Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.
about
Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas.PD-1 blockade in Hodgkin's lymphoma: learning new tricks from an old teacher.ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors.The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma.Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients.18F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.Anti-PD-1 Antibodies as a Therapeutic Strategy in Classical Hodgkin Lymphoma.The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study.Serious concerns on the inability of FDG-PET in excluding residual viable lymphoma.
P2860
Q38775871-7ED27BA7-F29E-46C5-BAA9-1BC739D1B85EQ38836081-AFA9F2BD-E995-460C-98D9-C6678BA4AA36Q38953155-E144366A-AF40-4A0A-8EC2-16D8F65E45B0Q39324849-D68F1B87-05CC-47D1-B26C-1A53CA90F084Q42287385-95EC5713-612B-4BC1-81B6-38A08DD91013Q42317563-C2B759B2-4276-435A-8ECD-FEF5DAAD0835Q44792403-B2DF499F-A17D-4B2B-A783-FE8DCF3516CCQ47808320-A27B913B-6BD9-46E7-82C5-DC8DDC3AE7CFQ48127652-4717FEAF-F177-4B0C-8D09-40FA8E0B9CBFQ48689919-19582C02-B2F9-45BB-95C0-15C6CF5512E2Q49821096-2070A218-E0B7-4671-80E0-A1DEB6606B8CQ50058136-898DACAB-5BF0-4E81-967C-A28F9301D24B
P2860
Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@ast
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@en
type
label
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@ast
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@en
prefLabel
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@ast
Interim Positron Emission Tomo ...... e II Part of the HD0801 Study.
@en
P2093
P50
P356
P1476
Interim Positron Emission Tomo ...... se II Part of the HD0801 Study
@en
P2093
Alessandro Broccoli
Alessandro Levis
Alessandro Pulsoni
Andrea Evangelista
Antonella Anastasia
Antonio Castagnoli
Armando Santoro
Caterina Stelitano
Chiara Rusconi
Daniela Maria Gioia
P304
P356
10.1200/JCO.2015.63.0699
P407
P50
P577
2016-02-16T00:00:00Z